Cytek biosciences earnings call
WebFeb 24, 2024 · Cytek Biosciences, Inc. (NASDAQ:NASDAQ:CTKB) Q4 2024 Earnings Conference Call February 23, 2024 5:00 PM ETCompany ParticipantsAlex Khan - … WebMar 1, 2024 · Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 40% and 3.07%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Cytek biosciences earnings call
Did you know?
WebFeb 23, 2024 · Cytek Biosciences expects full year 2024 revenue to be in the range of $160 million to $168 million. Webcast Information Cytek will host a conference call to discuss the fourth quarter 2024 financial results on Wednesday, February 23, 2024, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. WebFeb 28, 2024 · Other than Cytek’s Northern Lights CLC system, which is available for clinical use in China and the European Union, Cytek’s products are for research use only – not for use in diagnostic procedures. Stock Information $8.75 NASDAQ GS: CTKB 0 … The Investor Relations website contains information about Cytek Biosciences's … Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from … Mar 24, 2024: 144: Filed by "insiders" prior intended sale of restricted stock. Non … Cytek Biosciences Fourth Quarter and Full Year 2024 Earnings Conference Call. … Cytek Biosciences, CEO. Wenbin Jiang, Ph.D. has served as Cytek’s Chief … The Investor Relations website contains information about Cytek Biosciences's … Cytek was incorporated in Delaware in 2014 under the name Cytoville, Inc. In August …
WebMar 31, 2024 · Cytek Biosciences - CTKB News Today $9.19 +0.28 (+3.14%) (As of 03/31/2024 12:00 AM ET) Compare Today's Range $8.95 $9.39 50-Day Range $8.44 $13.47 52-Week Range $7.38 $16.05 Volume 1.11 million shs Average Volume 737,749 shs Market Capitalization $1.24 billion P/E Ratio 459.73 Dividend Yield N/A Price Target …
WebApr 10, 2024 · About the company. Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence … WebApr 13, 2024 · RBC Capital Markets is positief over het aandeel met een koopadvies. Voorheen was het koersdoel 579 USD, maar deze is licht aangepast naar 582 USD. 13 april 2024
WebFeb 6, 2024 · Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 28, 2024. Feb 07, 2024.
WebNov 8, 2024 · Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2024 Earnings Conference Call November 8, 2024 4:30 PM ET. Company Participants. Wenbin Jiang - Chief … try the swings they saidWebFeb 28, 2024 · Provides full year 2024 revenue guidance of $225 million to $235 million, or growth of 37% to 43% over full year 2024. FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) ( Nasdaq: CTKB) today reported financial results for the fourth quarter and year ended December … phillips andover mapWebNov 9, 2024 · Cytek Biosciences, Inc. (CTKB) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to … phillips andover museumWeb哪里可以找行业研究报告？三个皮匠报告网的最新栏目每日会更新大量报告，包括行业研究报告、市场调研报告、行业分析报告、外文报告、会议报告、招股书、白皮书、世界500强企业分析报告以及券商报告等内容的更新，通过最新栏目，大家可以快速找到自己想要的内容。 try the trainWebCytek is a leading cell analysis solutions company on a mission to advance cancer and cell biology research. Our re-imagined flow cytometry instruments, related products and services focus on delivering deep immune cell profiling benefits to more scientists. For Research Use Only. Not for use in diagnostic or therapeutic procedures. try the trade skill activity lost arkWebMar 1, 2024 · Cytek Biosciences, Inc. (NASDAQ:NASDAQ:CTKB) Q4 and Full Year 2024 Earnings Conference Call February 28, 2024 4:30 PM ETCompany ParticipantsPaul … trytheunfamiliarWebNov 9, 2024 · Cytek Biosciences, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $40.48 million for the quarter ended September 2024, missing the Zacks... try the troubleshooter